Detalhe da pesquisa
1.
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab.
Mol Ther
; 30(1): 468-484, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111559